Suppression and recovery of LPS-stimulated monocyte activity after trauma is correlated with increasing injury severity: A prospective clinical study

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 5, 2009, Pages 1273-1280

  Wutzler, Sebastian ^a,c   Maier, Marcus ^a   Lehnert, Mark ^a   Henrich, Dirk ^a   Walcher, Felix ^a   Maegele, Marc ^b   Laurer, Helmut ^a   Marzi, Ingo ^d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Hand und Wiederherstellungschirurgie   (Germany)

^d NONE

Author keywords

Cytokines; IL 1 3; Immune dysfunction; Monocytes; Multiple trauma

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROCALCITONIN;

ADULT; ARTICLE; BLOOD SAMPLING; BLUNT TRAUMA; CALCITONIN BLOOD LEVEL; CELL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HUMAN; INJURY SCALE; INJURY SEVERITY; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMATIC BRAIN INJURY; BLOOD; CELL CYCLE; CELL DEATH; CELL DIVISION; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; FOLLOW UP; INJURY; METABOLISM; MIDDLE AGED; MONITORING; MORTALITY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; BIOLOGICAL MARKERS; CELL CYCLE; CELL DEATH; CELL DIVISION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MONOCYTES; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMA CENTERS; WOUNDS AND INJURIES;

EID: 67649639479     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181968054     Document Type: Article

References (46)

1. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38:1336-1345.
2. Smith JW, Gamelli RL, Jones SB,- Shankar R. Immunologic responses to critical injury and sepsis. J Intensive Care Med. 2006;21:160-172.
3. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injurs. J Am Coll Surg. 2001;193:237-244.
4. Rose S, Marzi I. Mediators in polytrauma-pathophysiological significance and clinical relevance. Langenbeck's Arch Surg. 1998; 383:199-208.
5. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885- 891.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431-1433.
7. Lendemans S, Kreuzfelder E, Waydhas C, Nast-Kolb D, Flohe S. Clinical course and prognostic significance of immunological functional parameters after severe trauma. Unfallchirurg 2004; 107:203-210.
8. Fraunberger P, Wang Y Holler E. Prognostic value of interleukin 6, procalcitonin and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock. 2006;26:10-12.
9. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth. 1997; 78:201-219.
10. Sorl A, Rush BF Jr, Lysz TW, Smith S, Machiedo GW. The gut as source of sepsis after hemorrhagic shock. Am J Surg. 1988;155: 187-192.
11. Chen JD, Lapiere JC, Sauder DN, Peavey C, Woodley DT. Interleukin-1 alpha stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-alpha independent pathway. J Invest Dermatol. 1995;104:729-733.
12. Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;15:74-80.
13. Rodrick ML, Moss NM, Grbic JT, et al. Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol. 1992;12:440-450.
14. Granowitz EV, Porat R, Mier JW, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 1993;151:1637-1645.
15. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg. 1992; 79:757-760.
16. Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85:109-117.
17. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg. 2004;389:475-484.
18. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cell: IL-6 suppresses IL-1 and TNF. Blood. 1990; 75:40-47.
19. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991;38:1097-1101.
20. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL- 1 receptor antagonist and soluble tumor necrosis factor p55. Blood. 1994;83:113-118.
21. Flohé S, Flohé SB, Schade FU, Waydhas C. Immune response of severely injured patients-influence of surgical intervention and therapeutic impact. Langenbecks Arch Surg. 2007;392:639-648.
22. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury. 2007;38:1358-1364.
23. Keel M, Schregenberger N, Steckholzer U, et al. Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma. 1996; 41:430-437.
24. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
25. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complaex clinical outcome. Crit Care Med. 1995;23:1638-1652.
26. Bone RC. Let's agree on terminology: definitions of sepsis. Crit Care Med. 1991;19:973-976.
27. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). J Am Med Assoc. 1992; 268:3452-3455.
28. Hartung T, Docke WD, Gantner F, et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 1995;85:2482-2489.
29. Volk HD, Reinke P, Krausch D. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Int Care Med. 1996; 22:S474-S481.
30. Burger D, Dayer JM. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T-lymphocytes. Ann N Y Acad Sci. 2002;966:464-473.
31. Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med. 2003;31:243-247.
32. Munoz C, Carlet J, Fitting C, Misset B, Blenot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991;88:1747-1754.
33. Cao L, Lui C, Cai B, et al. Nuclear factor-kappa B expression in alveolar macraphages pf mechanically ventilated neonates with respiratory distress syndrome. Biol Neonate. 2004;86:116-123.
34. Busch CJ, Wanner GA, Menger MD, Vollmar B. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram:positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes. Inflamm Res. 2004;53:205-210.
35. Cassatella A. The production of cytokines by polymorphonuclear neutrophils. Immunol Today. 1995;16:21-26
36. Tschoeke SK, Ertel W. Immunoparalysis after multiple Trauma. Injury. 2007;38:1346-1357.
37. Lendemans S, Kreuzfelder E, Rani M, et al. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system. J Trauma. 2007;63:740-746.
38. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006;10:R1.
39. McGowan JE, Barnes MW, Finland N. Bacteremia at Boston City Hospital: occurence and mortality during 12 selected years (1935- 1972) with special reference to hospital-acquired cases. J Infect Dis. 1975;132:316-335.
40. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Chaudry IH. Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 1996;8:853-863.
41. Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine. 2001;14:162-169.
42. Frink M, Pape HC, van Griensven M, Krettek C, Chaudry IH, Hildebrand F. Influence of sex and age on mods and cytokines after multiple injuries. Shock 2007;27:151-156.
43. Choudhry MA, Bland KI, Chaudry IH. Trauma and immune response-Effect of gender differences. Injury. 2007;38:1382-1391.
44. Viselli SM, Stanziale S, Shults K, Kovacs WJ, Olsen NJ. Castration alters peripheral immune function in normal male mice. Immunology. 1995;84:337-342.
45. Walker SE, Besch Williford CL, Keisler DH. Accelerated deaths from systematic lupus erythematodes in NZB x NZW F, mice treated with testosteroneTblocking drug flutamide. J Lab Clin Med. 1994;124:401-407.
46. Ayala A, Ertel W, Chaudry IH. Trauma induced suppression of antigen presenting and expression of major histocompatibility class II antigen complex in leucocytes. Shock. 1996;5:79-90.